In primary breast cancer, the ER status was positive among 17 patients, accounting for 70.8% of the total, while it was negative in 7 patients, representing 29.2% of the cases; PR was positive in 10 patients (58.8%) and negative in 7 patients (41.2%). The gene discussed is ESR1; the disease is breast carcinoma.